The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reuters Business News Schedule at 0830 GMT/430AM ET

Tue, 08th May 2018 09:30

Editor: Keith Weir, +44 20 7542 8022

Global Picture Desk: +65 6870 3775

Global Graphics Desk: + 65 6870 3595

(All times GMT / ET)

Receive this schedule by email:

http://mediaexpress.reuters.com

TOP STORIES

Japan's Takeda clinches $62 bln deal to buy drugmaker Shire

LONDON/TOKYO - Takeda Pharmaceutical agrees to buyLondon-listed Shire for 45.3 billion pounds ($61.50 billion)after the Japanese company raises the amount of cash in itsoffer to secure a recommendation. (SHIRE-M&A/TAKEDA (UPDATE 3,PIX), moved, by Paul Sandle, Ben Hirschler and Sam Nussey, 765words)

Comcast prepares all-cash bid to gate-crash Disney-Fox deal

U.S. cable operator Comcast Corp is asking investment banksto increase a bridge financing facility by as much as $60billion so it can make an all-cash offer for the media assetsthat Twenty-First Century Fox Inc has agreed to sell to WaltDisney Co for $52 billion, three people familiar with the mattersay. (FOX-M&A/COMCAST (EXCLUSIVE, UPDATE 3, PIX, TV), moved, byGreg Roumeliotis and Liana B. Baker, 552 words)

Icahn, Deason want bid of at least $40 per share for Xerox

Carl Icahn and Darwin Deason, shareholders in Xerox Corp whooppose an agreed deal with Fujifilm Holdings, said they wouldconsider an all-cash bid of at least $40 per share - a 43percent premium to the Japanese firm's offer.(XEROX-M&A/FUJIFILM (UPDATE 6, PIX), moving shortly, by LahareeChatterjee, 617 words)

China April exports bounce back more than expected despiteUS trade brawl

BEIJING - China's exports rebound more strongly thanexpected in April after a surprise drop the previous month,suggesting global demand remains relatively resilient andproviding a cushion to the economy amid a heated trade disputewith the United States. (CHINA-ECONOMY/TRADE (UPDATE 2, PIX,GRAPHIC), moved, by Elias Glenn, 790 words)

+ See also:

USA-TRADE/CHINA-TALKS (UPDATE 1), moved, 360 words

MARKETS

Oil prices fall as market awaits Trump decision on Iran

TOKYO - Oil prices retreat from 3-1/2 year highs asinvestors waited on an announcement by President Donald Trump onwhether the United States will reimpose sanctions on Iran.(GLOBAL-OIL/ (UPDATE 2), moved, by Aaron Sheldrick, 385 words)

Dollar cements gains after scaling 2018 peak; euro struggles

LONDON - The dollar consolidates gains after scaling a 2018peak in the previous session as investors focus their attentionon U.S. President Donald Trump's decision about the future of aninternational nuclear agreement with Iran. (GLOBAL-FOREX/(UPDATE 2), moved, by Saikat Chatterjee, 391 words)

ECONOMY

Tax cuts, spending boost likely in budget as Australia eyesreturn to surplus

CANBERRA - Australia's centre-right government is expectedto announce hefty health and infrastructure spending and deliversome voter-sweetening tax cuts in an annual budget on Tuesdaythat unofficially kicks off campaigning for elections next year.(AUSTRALIA-POLITICS/BUDGET (UPDATE 2, PIX), moved, by SwatiPandey and Jane Wardell, 635 words)

Argentina stems peso bleeding but remains vulnerable tocapital flows

NEW YORK - Argentina's three recent interest rate increasesto halt the peso's collapse can be traced back to alate-December government press conference which have left thecountry more vulnerable to international investor sentiment andcapital flows. (ARGENTINA-RATE/WALLSTREET (ANALYSIS), moved, byRodrigo Campaos, 764 words)

Japan March household spending slumps, suggests economyslowed in Q1

TOKYO - Japanese household spending fell 0.7 percent inMarch from a year earlier to mark the second straight month ofdeclines, underscoring the view the economy suffered a temporarylull in the first quarter as bad weather hurt consumption.(JAPAN-ECONOMY/SPENDING (UPDATE 1), moved, by Leika Kihara, 216words)

NZ central bank governor Orr in spotlight as rates set tostay on hold

WELLINGTON - New Zealand's central bank is all but certainto keep rates on hold this week and signal no imminenttightening at a policy meeting that will be closely watched asthe first with both a new governor and an employment goalmandate. (NEWZEALAND-ECONOMY/RBNZ (PREVIEW), moved, by CharlotteGreenfield, 474 words)

COMPANIES

Walmart likely to announce Flipkart deal before end of thisweek -sources

MUMBAI/BENGALURU - Walmart is likely to announce itsmuch-anticipated deal to buy a controlling stake in Indiane-commerce player Flipkart before the end of this week, twosources said, in what is likely to be the U.S. retail giant'sbiggest acquisition of a business. (FLIPKART-M&A/WALMART (PIX),moved, by Sankalp Phartiyal and Nivedita Bhattacharjee, 460words)

Beauty products gloss over Zalando earnings squeeze

BERLIN - European online fashion retailer Zalando says thelaunch of beauty products in Germany had made a promising startand it saw a big jump in active customers in the first quarteralthough a late start to spring weighed on profitability.(ZALANDO-RESULTS/ (UPDATE 2), moving shortly, by Emma Thomasson,386 words)

S.Korea's SK Telecom, partner buy ADT Caps from Carlyle for$1.2 bln

SEOUL - South Korea's largest telecom firm, SK Telecom CoLtd, said on Tuesday it and a partner had decided to wholly buydomestic security systems company ADT Caps for about 1.28trillion won ($1.2 billion). (ADT CAPS-M&A/SK TELECOM (UPDATE1), moved, by Joyce Lee, 247 words)

ANALYSIS

Easy credit no more: how shocks from Australian banks'inquiry may squeeze a nation

SYDNEY - Australia's biggest banks are imposing stricterlending conditions on borrowers as damaging disclosures at aninquiry into financial-sector misconduct prompt fears theeconomy will be the victim of a new era of subdued creditgrowth. (AUSTRALIA-LENDING/ (ANALYSIS, PIX), moved, by JonathanBarrett and Tom Westbrook, 1064 words)

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.